Pmv Pharmaceuticals Inc (PMVP) — Long-term Investment Intensity
Pmv Pharmaceuticals Inc (PMVP) has a Long-term Investment Intensity of 3.9% as of June 2025. Long-term investments of $6.03 Million represent 3.9% of total assets of $152.85 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore Pmv Pharmaceuticals Inc (PMVP) cash conversion ratio to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Pmv Pharmaceuticals Inc Long-term Investment Intensity (2021–2024)
This chart shows how Pmv Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the intensity stands at 3.9%, reflecting long-term investments of $6.03 Million against total assets of $152.85 Million USD. Explore Pmv Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Pmv Pharmaceuticals Inc (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for Pmv Pharmaceuticals Inc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Pmv Pharmaceuticals Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 7.2% | $13.84 Million | $191.29 Million | ▼ -2.9 pp |
| 2023 | 10.1% | $25.50 Million | $252.15 Million | ▲ +9.2 pp |
| 2022 | 0.9% | $2.50 Million | $270.31 Million | ▼ -4.2 pp |
| 2021 | 5.1% | $16.91 Million | $331.57 Million | — |